Focal Brainstem Glioma

Focal brainstem gliomas are a rare type of brainstem glioma that develops from glial (or supportive) tissue in the brain, which supports and protects the brains neurons. More specifically, it develops in the midbrain or medulla portions of the brainstem, which is found at the base of the brain.

The brainstem is a thin, stalk-like structure that connects the brain and the spinal cord. It is divided into three sections: the midbrain (or mesencephalon), pons (or metencephalon), and medulla (or medulla oblongata). Each component of the brainstem works together to control and regulate vital bodily functions, such as breathing, heart rate, blood pressure, as well as the nerves and muscles used for seeing, hearing, walking, talking, and eating.

There are two main types of brainstem gliomas in children: Diffuse Intrinsic Pontine Glioma (DIPG) and focal brainstem gliomas. Focal brain stem gliomas are well-contained and generally only found in one area. These tumours are generally benign or low grade, and often has a better prognosis than DIPG.  Comparatively, DIPG has a diffuse nature, which means the tumour is spread out and difficult to treat. These tumours are more common, but generally don’t have as good of a prognosis. For more information on DIPG, please refer to the Rare Cancers Australia DIPG page.

Focal brainstem gliomas are almost exclusively diagnosed in children, most commonly between the ages of five and nine. However, anyone can develop this disease.

Types of Focal Brainstem Gliomas

There are three primary subtypes of focal brainstem gliomas, which are classified by the type of cells the cancer develops from.

Pilocytic Astrocytoma

Pilocytic astrocytoma, also known as juvenile astrocytoma, is a slow growing subtype of astrocytoma that primarily affects children. It is classified as a grade I tumour, and develops slowly over time. Pilocytic astrocytomas generally non-aggressive, and often has a good prognosis. For more information on pilocytic astrocytomas, please refer to the Rare Cancers Australia Astrocytoma page.

Ganglioglioma

Gangliogliomas are rare types of tumours that generally develop in the central nervous system (CNS). More specifically, they develop from ganglia in the CNS, which are a group of neuronal bodies which sends messages to the brain relating to touch, smell, taste, sound, and visual stimuli. While gangliogliomas are generally benign (non-cancerous), in rare cases they may become malignant (cancerous). For more information on gangliogliomas, please refer to the Rare Cancers Australia Ganglioglioma page.

Oligodendroglioma

Oligodendrogliomas are a common type of glioma, which develop from the glial (or supportive) cells in the central nervous system (CNS). More specifically, they develop from a type of glial cell called oligodendrocytes, which produce a fatty, white substance known as myelin. For more information on oligodendrogliomas, please refer to the Rare Cancers Australia Oligodendroglioma page.

Fibrillary Astrocytoma

Fibrillary astrocytomas are a common type of diffuse astrocytoma, and a less common type of focal brainstem glioma. This type of cancer is generally classified as a grade II tumour, is widespread, and has poorly defined borders (diffuse). This type of tumour can be aggressive, and can have a good prognosis when found early. For more information on diffuse astrocytomas, please refer to the Rare Cancers Australia Astrocytoma page.

Glioblastoma

Glioblastomas, also known as glioblastoma multiforme (GBM), are a common type of brain tumour, but a rare type of focal brainstem glioma. Its name is derived from its cellular appearance under the microscope, which is often highly varied. GBM is generally classified as a high-grade brain tumour, are often highly aggressive tumours, and may not have as good of a prognosis as other types of focal brainstem glioma. For more information on GBM please refer to the Rare Cancers Australia Glioblastoma page.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, brain cancers are rarely staged, as they rarely spread to other parts of the body. Instead, they are generally graded.

Focal brainstem gliomas are generally graded by subtype:

  • Grade I (low-grade) tumours: cancer cells present as slightly abnormal and are usually slow growing. Includes the subtypes pilocytic astrocytoma, ganglioglioma and oligodendroglioma.
  • Grade II (intermediate-grade) tumours: cancer cells present as abnormal and grow faster than grade-I tumours. Includes fibrillary astrocytoma.
  • Grade III/IV (high grade) tumours: cancer cells present as very abnormal and grow quickly. Includes glioblastoma/GBM.

Your doctor may also recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including location, age, stage of disease and overall health.

Treatment options for focal brainstem gliomas may include:

  • Surgery to remove as much of the tumour as possible (may not always be an option).
  • Shunt insertion.
  • Watch and wait.
  • Radiation therapy.
  • Chemotherapy.
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare focal brainstem gliomas are, there has been limited research done into the risk factors of this disease. However, some recent research has suggested that there is a potential link to certain genetic disorders, such as neurofibromatosis type 1 (NF1).

Symptoms

Patients with a focal brainstem glioma may appear asymptomatic in the early stages of disease. As the tumour progresses, some of the following symptoms may appear:

  • Problems controlling eye movement, facial expressions, chewing and/or swallowing (as a result of nerve compression in the brain).
  • Slurred speech.
  • Difficulties with balance.
  • Hydrocephalus.
  • Headaches (often after waking up in the morning).
  • Nausea and/or vomiting (generally worse in the morning).
  • Irritability.
  • Blurred or double vision.
  • Seizures.
  • Lethargy.
  • Fatigue.
  • Changes in eating habits/appetite.
  • Difficulty walking.
  • Personality changes.
  • Enlarged fontanelles (soft spots on an infant’s head between the bony plates of the skull).
  • Enlarged head (more common in infants).
  • Facial drooping.
  • Difficulties urinating.
  • Weakness in the arms and/or the legs.
  • Clumsiness.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have a focal brainstem glioma,  they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
  • Blood tests.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.